linked-reads genomics and spatial transcriptomics. The company's products include Single Cell Gene Expression, Immune Profiling, CNV, ATAC, and Genome and Exome. 10X Genomics was founded by Serge ...

10x Genomics (US) 10x Genomics is a major ... Visium Spatial Gene Expression and Xenium In Situ platforms for spatial and transcriptomics research. These tools enable scientists to map gene ...

linked-reads genomics and spatial transcriptomics. The company’s products include Single Cell Gene Expression, Immune Profiling, CNV, ATAC, and Genome and Exome. 10X Genomics was founded by ...

We recently compiled a list of the Cathie Wood’s Stock Portfolio: 2025 Stock Picks. In this article, we are going to take a ...

10x Genomics excels in single-cell and spatial technologies but faces significant challenges. Despite an EPS beat, revenue fell 1% due to sales disruption and competitive pricing. The company's ...

The scope of the report covers detailed information regarding the major factors, such as drivers, challenges, opportunities, and restraints influencing the growth of the spatial genomics & ...

Leerink Partners analyst Puneet Souda reaffirmed his Buy rating on 10x Genomics, Inc. (NASDAQ:TXG) on October 30, 2024, with a $25.00 price target. The company’s strong single-cell and spatial ...

Genomics (TXG – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Michael Ryskin from ...

In 2023, the product segment accounted for the highest share of the spatial genomics and transcriptomics market. The growing demand for high-resolution spatial gene and protein expression data in ...

DELRAY BEACH, Fla., Jan. 13, 2025 /PRNewswire/ -- The global Spatial Genomics & Transcriptomics market is expected to grow to USD 995.7 Million by 2029, up from USD 554.5 Million in 2024, at a ...